BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 22813447)

  • 1. Uveal melanoma trapped in the temple of doom.
    Shields CL; Ganguly A; O'Brien J; Sato T; Shields JA
    Am J Ophthalmol; 2012 Aug; 154(2):219-21. PubMed ID: 22813447
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognosis of uveal melanoma in 500 cases using genetic testing of fine-needle aspiration biopsy specimens.
    Shields CL; Ganguly A; Bianciotto CG; Turaka K; Tavallali A; Shields JA
    Ophthalmology; 2011 Feb; 118(2):396-401. PubMed ID: 20869116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic investigations of posterior uveal melanoma.
    Hovland PG; Trempe C
    Semin Ophthalmol; 2005; 20(4):231-8. PubMed ID: 16352494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased p21-activated kinase-1 expression is associated with invasive potential in uveal melanoma.
    Pavey S; Zuidervaart W; van Nieuwpoort F; Packer L; Jager M; Gruis N; Hayward N
    Melanoma Res; 2006 Aug; 16(4):285-96. PubMed ID: 16845324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uveal melanoma: prognostication.
    Turell ME; Tubbs RR; Biscotti CV; Singh AD
    Monogr Clin Cytol; 2012; 21():55-60. PubMed ID: 22024584
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection of c-myc amplification in uveal melanoma by fluorescent in situ hybridization.
    Parrella P; Caballero OL; Sidransky D; Merbs SL
    Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1679-84. PubMed ID: 11431428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genomic techniques used in uveal melanoma: a literature review].
    Abi-Ayad N; Kodjikian L; Couturier J
    J Fr Ophtalmol; 2011 Apr; 34(4):259-64. PubMed ID: 21439677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Connection between uveal melanoma and dysplastic naevus syndrome].
    Hammer H; Tóth-Molnár E; Oláh J; Dobozy A
    Magy Onkol; 2005; 49(1):15-8. PubMed ID: 15902328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytokines in uveal melanoma. Original title: uveal melanoma cytokines].
    Filer RS; Song JC; Char DH; Kaleta-Michaels S
    Klin Monbl Augenheilkd; 1993 Mar; 202(3):174-9. PubMed ID: 8510410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NBS1 expression as a prognostic marker in uveal melanoma.
    Ehlers JP; Harbour JW
    Clin Cancer Res; 2005 Mar; 11(5):1849-53. PubMed ID: 15756009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA index and % S phase fraction in posterior uveal melanoma: a 5 year prospective study of fresh tissue using flow cytometry.
    Richardson RP; Lawry L; Rees RC; Rennie IG
    Eye (Lond); 1997; 11 ( Pt 5)():629-34. PubMed ID: 9474308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DDEF1 is located in an amplified region of chromosome 8q and is overexpressed in uveal melanoma.
    Ehlers JP; Worley L; Onken MD; Harbour JW
    Clin Cancer Res; 2005 May; 11(10):3609-13. PubMed ID: 15897555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrophosphorolysis detects B-RAF mutations in primary uveal melanoma.
    Maat W; Kilic E; Luyten GP; de Klein A; Jager MJ; Gruis NA; Van der Velden PA
    Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):23-7. PubMed ID: 18172070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of gene expression analysis in uveal melanoma in comparison to standard risk factors for risk assessment of subsequent metastases.
    Petrausch U; Martus P; Tönnies H; Bechrakis NE; Lenze D; Wansel S; Hummel M; Bornfeld N; Thiel E; Foerster MH; Keilholz U
    Eye (Lond); 2008 Aug; 22(8):997-1007. PubMed ID: 17384575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical appraisal of the prognostic and predictive factors for uveal malignant melanoma.
    Mudhar HS; Parsons MA; Sisley K; Rundle P; Singh A; Rennie IG
    Histopathology; 2004 Jul; 45(1):1-12. PubMed ID: 15228438
    [No Abstract]   [Full Text] [Related]  

  • 16. Suppression of α5 gene expression is closely related to the tumorigenic properties of uveal melanoma cell lines.
    Landreville S; Vigneault F; Bergeron MA; Leclerc S; Gaudreault M; Morcos M; Mouriaux F; Salesse C; Guérin SL
    Pigment Cell Melanoma Res; 2011 Aug; 24(4):643-55. PubMed ID: 21592318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of bcl-2 in uveal malignant melanoma.
    Jay V; Yi Q; Hunter WS; Zielenska M
    Arch Pathol Lab Med; 1996 May; 120(5):497-8. PubMed ID: 8639055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma.
    Aalto Y; Eriksson L; Seregard S; Larsson O; Knuutila S
    Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):313-7. PubMed ID: 11157859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometry measurement of nuclear RNA content in uveal melanoma.
    Chen TC; Char DH; Waldman F; Juster RP
    Ophthalmic Res; 1990; 22(3):187-93. PubMed ID: 2166933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of heterozygosity on chromosomes 3, 9, 13, and 17, including the retinoblastoma locus, in uveal melanoma.
    Scholes AG; Liloglou T; Maloney P; Hagan S; Nunn J; Hiscott P; Damato BE; Grierson I; Field JK
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2472-7. PubMed ID: 11581185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.